Zhengyan Kan

11.0k total citations · 3 hit papers
28 papers, 3.9k citations indexed

About

Zhengyan Kan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhengyan Kan has authored 28 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhengyan Kan's work include RNA and protein synthesis mechanisms (8 papers), Cancer Genomics and Diagnostics (6 papers) and RNA Research and Splicing (6 papers). Zhengyan Kan is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), Cancer Genomics and Diagnostics (6 papers) and RNA Research and Splicing (6 papers). Zhengyan Kan collaborates with scholars based in United States, South Korea and China. Zhengyan Kan's co-authors include Jason M. Johnson, John C. Castle, Philip W. Garrett-Engele, Warren Gish, Christopher D. Armour, Eric E. Schadt, Daniel Shoemaker, Roland Stoughton, Patrick Loerch and Eric C. Rouchka and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Zhengyan Kan

27 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays

2003 1.1k citations Jason M. Johnson, John C. Castle et al. Science profile →
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer

2017 691 citations Woosung Chung, Hye Hyeon Eum et al. Nature Communications profile →
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma

2009 670 citations Robert L. Yauch, Gerrit J.P. Dijkgraaf et al. Science profile →

Peers

Countries citing papers authored by Zhengyan Kan

Since Specialization

Citations

This map shows the geographic impact of Zhengyan Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyan Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyan Kan more than expected).

Fields of papers citing papers by Zhengyan Kan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengyan Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyan Kan. The network helps show where Zhengyan Kan may publish in the future.

Co-authorship network of co-authors of Zhengyan Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyan Kan. A scholar is included among the top collaborators of Zhengyan Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyan Kan. Zhengyan Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COMPKE: Complex Question Answering under Knowledge Editing 2025 ·(unknown), Zhengyan Kan, Zhuoran Zhang, Muhammad Ali, (unknown), Di Wang	0
2	Reprogramming cysteine metabolism via METTL14-SLC7A11 axis promotes the progression of NAFLD and hepatocellular carcinoma 2025 ·Life Sciences ·Xingkang He, (unknown), Guangyu Lu, (unknown), Xue Yang, Zhengyan Kan, Yuwei Li, (unknown), Xianjun Zhu, Zhenglin Yang, Ziyan Wang	1
3	Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors 2025 ·Nature Communications ·Zhengyan Kan, Ji Wen, Vinícius Bonato, Jennifer Webster, Wenjing Yang, Ivanov Vv, Kimberly H. Kim, Whijae Roh, Chaoting Liu, Xinmeng Jasmine Mu, (unknown), Jon A. Oyer, Todd VanArsdale, Paul A. Rejto, Jadwiga Biénkowska	3
4	Prospective longitudinal multi-omics study of palbociclib resistance in hormone receptor+/HER2- metastatic breast cancer. 2021 ·Journal of Clinical Oncology ·Yeon Hee Park, Seock‐Ah Im, Kyunghee Park, Ji Wen, Ahrum Min, Vinícius Bonato, Seri Park, Sripad Ram, Dae‐Won Lee, Ji‐Yeon Kim, Kyung-Hun Lee, Won‐Chul Lee, Ji‐Sook Lee, (unknown), Won‐Woo Lee, Yoon‐La Choi, Scott L. Weinrich, Han Suk Ryu, Woong‐Yang Park, Zhengyan Kan	8
5	Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer breakdown → 2017 ·Nature Communications ·Woosung Chung, Hye Hyeon Eum, Hae‐Ock Lee, Kyung Min Lee, Han‐Byoel Lee, Kyu-Tae Kim, Han Suk Ryu, Sangmin Kim, Jeong Eon Lee, Yeon Hee Park, Zhengyan Kan, Wonshik Han, Woong‐Yang Park	691
6	P1.01-016 Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib 2017 ·Journal of Thoracic Oncology ·Benjamin Solomon, Jean‐Charles Soria, Fiona Blackhall, Alice T. Shaw, D. Ross Camidge, D. Kim, Tony Mok, Julio Fernandez-Banet, Zhengyan Kan, (unknown), (unknown), (unknown)	1
7	Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma 2014 ·Genomics ·Julio Fernandez-Banet, Nikki P. Lee, Kin Chan, Huan Gao, Xiao Liu, Wing‐Kin Sung, Winnie Tan, Sheung Tat Fan, Ronnie T.P. Poon, Shiyong Li, Keith A. Ching, Paul A. Rejto, Mao Mao, Zhengyan Kan	44
8	Coevolution of PDZ domain–ligand interactions analyzed by high-throughput phage display and deep sequencing 2010 ·Molecular BioSystems ·Andreas Ernst, David Gfeller, Zhengyan Kan, Somasekar Seshagiri, Philip M. Kim, Gary D. Bader, Sachdev S. Sidhu	97
9	Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma breakdown → 2009 ·Science ·Robert L. Yauch, Gerrit J.P. Dijkgraaf, Bruno Alicke, Thomas Januario, Christina P. Ahn, Thomas Holcomb, Kanan Pujara, Jeremy Stinson, Christopher A. Callahan, Tracy Tang, J. Fernando Bazán, Zhengyan Kan, Somasekar Seshagiri, Christine L. Hann, Stephen E. Gould, Jennifer A. Low, Charles M. Rudin, Frédéric J. de Sauvage	670
10	ACC2 Is Expressed at High Levels Human White Adipose and Has an Isoform with a Novel N-Terminus 2009 ·PLoS ONE ·John C. Castle, Yoshikazu Hara, Christopher K. Raymond, Philip W. Garrett-Engele, Kenji Ohwaki, Zhengyan Kan, Jun Kusunoki, Jason M. Johnson	31
11	High-throughput, high-accuracy array-based resequencing 2009 ·Proceedings of the National Academy of Sciences ·Jianbiao Zheng, Martin Moorhead, Li Weng, Farooq Siddiqui, Victoria Carlton, James Ireland, (unknown), (unknown), Jennifer L. Wilkins, Sean Xu Qi Lin, Zhengyan Kan, Somasekar Seshagiri, Ronald W. Davis, Malek Faham	14
12	PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6) 2007 ·Journal of Pharmacology and Experimental Therapeutics ·York-Fong Cheung, Zhengyan Kan, Philip W. Garrett-Engele, Irene Gall, Hannah Murdoch, George S. Baillie, Luiz Miguel Camargo, Jason M. Johnson, Miles D. Houslay, John C. Castle	52
13	An Intronic Signal for Alternative Splicing in the Human Genome 2007 ·PLoS ONE ·Necat Havlioglu, Jun Wang, Kazuo Fushimi, Maria D. Vibranovski, Zhengyan Kan, Warren Gish, A. N. Fedorov, Manyuan Long, Jane Y. Wu	15
14	Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection 2007 ·Nature Methods ·Brock A. Peters, Zhengyan Kan, Dragan Sebisanovic, Kanan Pujara, Zhiyong Wang, (unknown), Bernard Chow, Jeremy Stinson, Victoria Carlton, Thinh Q. Pham, Howard M. Stern, Paul Waring, Kenneth J. Hillan, David A. Eberhard, Frédéric J. de Sauvage, Jianbiao Zheng, Malek Faham, Somasekar Seshagiri	5
15	Evolutionarily conserved and diverged alternative splicing events show different expression and functional profiles 2005 ·Nucleic Acids Research ·Zhengyan Kan	57
16	Expression of Alternatively Spliced Sodium Channel α-Subunit Genes 2004 ·Journal of Biological Chemistry ·Christopher K. Raymond, John C. Castle, Philip W. Garrett-Engele, Christopher D. Armour, Zhengyan Kan, Nicholas F. Tsinoremas, Jason M. Johnson	100
17	Selecting for Functional Alternative Splices in ESTs 2002 ·Genome Research ·Zhengyan Kan, David States, Warren Gish	155
18	Gene Structure Prediction and Alternative Splicing Analysis Using Genomically Aligned ESTs 2001 ·Genome Research ·Zhengyan Kan, Eric C. Rouchka, Warren Gish, David J. States	306
19	Gambaran Pengetahuan, Sikap dan Perilaku Ibu hamil Terhadap Cakupan Kunjungan Pertama (K1) Di Puskesmas Lemah Wungkuk Kota Cirebon Tahun 2007 2000 ·PubMed ·Zhengyan Kan, Warren Gish, Eric C. Rouchka, Jarret Glasscock, David States	13
20	Antigen receptor engagement delivers a stop signal to migrating T lymphocytes 1997 ·Proceedings of the National Academy of Sciences ·Michael L. Dustin, Shannon K. Bromley, Zhengyan Kan, Daniel A. Peterson, Emil R. Unanue	327

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact